Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism

1. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B (2001) Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 142:838–842. doi:10.1067/mhj.2001. 119370 2. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V (1999) Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44:121–131. doi:10.1016/S0008- 6363(99)00178-9 3. Burstein B, Libby E, Calderone A, Nattel S (2008) Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117:1630–1641. doi:10.1161/ CIRCULATIONAHA.107.748053 4. Burstein B, Nattel S (2008) Atrial fibrosis: mechanism and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802–809. doi:10.1016/j.jacc.2007.09.064 5. Cameiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RLP, Santos RAS, Barreto-Chaves MLM (2010) Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 105:325–335. doi:10.1007/s00395-010-0089-0 6. Chen RN, Huang YH, Lin YC, Yeh CT, Liang Y, Chen SL, Lin KH (2008) Thyroid hormone promotes cell invasion through activation of furin expression 25 in human hepatoma cell lines. Endocrinology 149:3817–3831. doi:10.1210/en.2007-0989 7. Chen WJ, Lin KH, Lee YS (2000) Molecular characterization of myocardial fibrosis during hypothyroidism. Mol Cell Endocrinol 162:45–55. doi:10.1016/S0303-7207(00)00203-3 8. Chen WJ, Pang JHS, Lin KH, Lee DY, Hsu LA, Kuo CT (2010) Propylthiouracil, independent of its antithyroid effect, promotes VSMC differentiation via PTEN induction. Basic Res Cardiol 105:19–28. doi:10.1007/s00395-009-0045-z 9. Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI (2002) Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 39:366–372. doi:10.1016/S0735-1097(01)01731-4 10. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95:2979–2984 11. Diniz GP, Cameiro-Ramos MS, Barreto-Chaves MLM (2009) Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3b/mTOR signaling pathway. Basic Res Cardiol 104:653–667. doi: 10.1007/s00395-009-0043-1 12. Glass CK (1994) Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391–407. doi:10.1210/edrv-15-3-391 13. Harvey CB, Williams GR (2002) Mechanism of thyroid hormone action. Thyroid 12:441–446. doi:10.1089/105072502760143791 14. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen NH, Scanlan TS, Moskowitz MA, Cheng SY, Liao JK (2006) Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103:14104–14109. doi: 10.1073/pnas.0601600103 Basic Res Cardiol (2011) 106:163–174 173 123 15. Johannessen M, Delghandi MP, Moens U (2004) What turns CREB on? Cell Signal 16:1211–1227. doi:10.1016/j.cellsig. 2004.05.001 16. Kahaly GJ, Dillmann WH (2005) Thyroid hormone action in the heart. Endocr Rev 26:704–728. doi:10.1210/er.2003-0033 17. Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501–509 18. Komiya N, Isomoto S, Nakao K, Hayano M, Yano K (2002) Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin Endocrinol 56:39–44. doi:27101046/j0300-0664200 101459x 19. Laflamme L, Hamann G, Messier N, Maltais S, Langlois MF (2002) RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. J Mol Endocrinol 29:61–72. doi:10.1677/jme.0.0290061 20. Mai